Economic TimesLean R·
Zydus Lifesciences Q1 Results: Net profit down 36% at Rs 939.8 crore
Zydus Lifesciences reported a significant year-on-year decline of thirty-six percent in net profit for the first quarter, despite a robust twenty-two percent increase in operational revenue, reaching eight thousand seventeen crore rupees. The company experienced profitability challenges with an EBITDA reduction of seven point six percent compared to the previous year. Following the announcement, their stock price saw an uptick. Zydus is a prominent player in the global pharmaceutical landscape.
Read at Economic Times →
